Drug-induced Linear Immunoglobulin A Bullous Disease That Clinically Mimics Toxic Epidermal Necrolysis
| Autor: | Mona Z. Mofid, Andrew M. Munster, Hossein C. Nousari, Constantino Costarangos, Benjamin Bernstein, Lesley Wong |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
Immunoglobulin A
Phenytoin Drug medicine.medical_specialty Pemphigoid media_common.quotation_subject Diagnosis Differential Vancomycin Pemphigoid Bullous medicine Bullous disease Humans skin and connective tissue diseases General Nursing media_common Aged Aged 80 and over Subepidermal blistering integumentary system biology business.industry Rehabilitation medicine.disease Dermatology Toxic epidermal necrolysis Anti-Bacterial Agents Stevens-Johnson Syndrome General Health Professions biology.protein Emergency Medicine Female Surgery business medicine.drug |
| Zdroj: | Journal of Burn Care & Rehabilitation. 21:246-247 |
| ISSN: | 0273-8481 |
| Popis: | Drug-induced linear immunoglobulin A bullous disease is a subepidermal blistering disorder that most commonly occurs after exposure to vancomycin. It can clinically mimic toxic epidermolytic necrolysis. We describe an 87-year-old white woman in whom linear immunoglobulin A bullous disease developed while she was taking vancomycin and phenytoin. A few days after the linear immunoglobulin A bullous disease developed, both medications were discontinued. No new bullae developed, and the eruption completely resolved within 2 weeks. The patient was treated with only topical therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|